NanoRepro AG
ISIN: DE0006577109 | Ticker: NN6 | LEI: 3912008FCA63AGIMEV74
Country: Germany
NanoRepro AG, based in Marburg an der Lahn, specializes in the development, manufacture and national and international distribution of medical self-tests and is primarily active in health planning and prevention.
The company addresses a rapidly growing market, which is characterized by the steadily increasing health awareness of the population and will continue to gain in importance in the coming years.
NanoRepro has 24 rapid tests in its portfolio and is continuously expanding it. Among others, the company has already established 2 pregnancy tests, a test for male fertility determination, a test for gastric health as well as a range of different allergy tests and tests for preventive health care on the market.
2006
Served areaWorldwide
HeadquartersUntergasse 8, 35037 Marburg – Germany
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 04.08.23 | Jüngst, Lisa | Board | Buy | EUR 45,880.06 |
| 02.08.23 | Stiller, Dr. Olaf | Supervisory board | Buy | EUR 21,964.00 |
| 02.08.23 | Stiller, Dr. Olaf | Supervisory board | Buy | EUR 9,670.30 |
| 02.08.23 | Stiller, Johanna | Close relation | Buy | EUR 5,625.00 |
DE0006577109
LEI3912008FCA63AGIMEV74
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.